Rockefeller Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $27K | Hold |
1,422
| – | – | ﹤0.01% | 454 |
|
|
2017
Q3 | $25K | Hold |
1,422
| – | – | ﹤0.01% | 462 |
|
|
2017
Q2 | $47K | Hold |
1,422
| – | – | ﹤0.01% | 384 |
|
|
2017
Q1 | $46K | Hold |
1,422
| – | – | ﹤0.01% | 404 |
|
|
2016
Q4 | $52K | Buy |
1,422
+72
| +5% | +$2.63K | ﹤0.01% | 418 |
|
|
2016
Q3 | $62K | Hold |
1,350
| – | – | ﹤0.01% | 383 |
|
|
2016
Q2 | $68K | Sell |
1,350
-1,560
| -54% | -$78.6K | ﹤0.01% | 382 |
|
|
2016
Q1 | $156K | Buy |
2,910
+1,063
| +58% | +$57K | ﹤0.01% | 338 |
|
|
2015
Q4 | $121K | Hold |
1,847
| – | – | ﹤0.01% | 377 |
|
|
2015
Q3 | $104K | Buy |
1,847
+497
| +37% | +$28K | ﹤0.01% | 377 |
|
|
2015
Q2 | $80K | Sell |
1,350
-3,500
| -72% | -$207K | ﹤0.01% | 379 |
|
|
2015
Q1 | $302K | Buy |
4,850
+2,710
| +127% | +$169K | 0.01% | 285 |
|
|
2014
Q4 | $123K | Buy |
2,140
+790
| +59% | +$45.4K | ﹤0.01% | 332 |
|
|
2014
Q3 | $73K | Sell |
1,350
-470
| -26% | -$25.4K | ﹤0.01% | 389 |
|
|
2014
Q2 | $95K | Buy |
1,820
+470
| +35% | +$24.5K | ﹤0.01% | 383 |
|
|
2014
Q1 | $71K | Hold |
1,350
| – | – | ﹤0.01% | 413 |
|
|
2013
Q4 | $54K | Hold |
1,350
| – | – | ﹤0.01% | 415 |
|
|
2013
Q3 | $51K | Hold |
1,350
| – | – | ﹤0.01% | 416 |
|
|
2013
Q2 | $53K | Buy |
+1,350
| New | +$53K | ﹤0.01% | 414 |
|